Pharmaceutical News

RSS

New method for qualifying safe drug dosing regimens in pediatrics

Determining safe yet effective drug dosages for children is an ongoing challenge for pharmaceutical companies and medical doctors alike.

6 May 2021

This small Canadian drugmaker wants to make J&J vaccines for poor nations. It needs more than a patent waiver.

Biolyse Pharma Corp., which makes a cancer medication, was gearing up to start making generic biologic drugs, made from living organisms. Then the pandemic hit.

6 May 2021

KHN’s ‘What the Health?’: Sharing vaccines with the world

The Biden administration — keeping a campaign promise — announced it would back a temporary waiver of patent protections for the covid-19 vaccines, arousing the ire of the drug industry.

6 May 2021

Many adults with hypertension may be taking other medications that could raise blood pressure

Nearly 1 in 5 adults with high blood pressure, a leading risk factor for heart disease and stroke, also take a medicine that could be elevating their blood pressure, according to new research presented at the American College of Cardiology's 70th Annual Scientific Session.

6 May 2021

Personalized medicines could be manufactured with 3D printing technology

Customized medicines could one day be manufactured to patients’ individual needs, with University of East Anglia (UEA) researchers investigating technology to 3D ‘print’ pills.

6 May 2021

Study: Millions of COVID-19 cases can be prevented by reaching higher vaccination coverage levels

With around 30 percent of the U.S. population now fully vaccinated, the rate of daily vaccinations has started to slow, raising concerns that greater efforts and investments may be needed to reach higher coverage levels.

6 May 2021

Study examines artemisinin-based combination therapy as first-line treatment for malaria

When a mosquito begins to nibble on you, it is not merely feeding on your blood, it is also injecting its saliva into your skin. If that saliva happens to be full of parasites carrying malaria or other diseases from its last victim, then most likely you will become infected, too.

6 May 2021

WHO hails Sweden’s announcement to share 1 million doses of AstraZeneca vaccine with COVAX

WHO Dr Tedros Adhanom Ghebreyesus welcomed the Government of Sweden's announcement today to share 1 million doses of the AstraZeneca vaccine with the COVAX Facility to provide life-saving vaccines to people at risk from COVID-19 in low income countries.

6 May 2021

World Health Organization lists Moderna COVID-19 vaccine for emergency use

Today, WHO listed the Moderna COVID-19 vaccine (mRNA 1273) for emergency use, making it the fifth vaccine to receive emergency validation from WHO.

6 May 2021

New study documents possible adverse events in relation to Vaxzevria COVID-19 vaccine

The new Danish-Norwegian study is the first study to document possible adverse events in relation to the COVID-19 vaccine Vaxzevria from AstraZeneca, in which all vaccine recipients have been followed systematically, as opposed to previous studies, which have relied primarily on reported adverse reactions.

6 May 2021

Novel CBD analog alleviates pain in mouse model of chemotherapy-induced peripheral neuropathy

For patients with chronic pain, ineffective treatments, lowered work productivity, and other factors often coalesce, fueling feelings of hopelessness and anxiety and setting the stage for even bigger problems, including substance use disorders.

5 May 2021

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.

5 May 2021

Covid shot in the arm not enough to keep pharmacies in business

Tobin's pharmacy and department store had already stocked its shelves with Easter and Mother's Day items last spring, and the staff had just placed the Christmas orders.

5 May 2021

Study reveals missed opportunities to deliver essential preventive care to lupus patients

A new study published in Arthritis Care & Research indicates that few individuals with the autoimmune disease lupus who were publicly insured through Medicaid received recommended vaccines in 2000-2010.

5 May 2021

$Erythropoietin treatment may increase the risk of hip fractures in individuals with kidney failure$

Erythropoietin treatment may increase the risk of hip fractures in individuals with kidney failure

Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures.

5 May 2021

New insights on how hospitalized patients develop liver injury from taking different drugs

A new study published in the British Journal of Clinical Pharmacology provides insights on how common hospitalized patients develop liver injury from taking different medications.

5 May 2021

Generic drugs for hypertension offer a great alternative to brand-name counterparts

Hypertension is a common medical condition and a primary cause of cardiovascular diseases and stroke worldwide.

5 May 2021

Study analyzes two different classes of drugs in a large group of preschoolers with ADHD

In a multi-institutional study, researchers in the Developmental-Behavioral Pediatrics Research Network (DBPNet), led by Children's Hospital of Philadelphia (CHOP), have conducted the first and largest analysis to date comparing the effectiveness and side effects of stimulants like methylphenidate (Ritalin) and alpha-adrenergic agonists like guanfacine (Tenex) in preschool-age children.

5 May 2021

Emergency physicians use heparin alternative to treat vaccine-induced blood clot

A new case report, detailed in Annals of Emergency Medicine, is the first known case of a patient with VITT (vaccine-induced thrombotic thrombocytopenia) treated with a heparin alternative following the Centers for Disease Control and Prevention (CDC) guidance.

5 May 2021

Moderna COVID-19 vaccine makes it on WHO Emergency Use Listing

Moderna has announced Emergency Use Listing granted by the World Health Organization for its COVID-19 mRNA vaccine.

4 May 2021

Pharmaceutical News

New method for qualifying safe drug dosing regimens in pediatrics

This small Canadian drugmaker wants to make J&J vaccines for poor nations. It needs more than a patent waiver.

KHN’s ‘What the Health?’: Sharing vaccines with the world

Many adults with hypertension may be taking other medications that could raise blood pressure

Personalized medicines could be manufactured with 3D printing technology

Study: Millions of COVID-19 cases can be prevented by reaching higher vaccination coverage levels

Study examines artemisinin-based combination therapy as first-line treatment for malaria

WHO hails Sweden’s announcement to share 1 million doses of AstraZeneca vaccine with COVAX

World Health Organization lists Moderna COVID-19 vaccine for emergency use

New study documents possible adverse events in relation to Vaxzevria COVID-19 vaccine

Novel CBD analog alleviates pain in mouse model of chemotherapy-induced peripheral neuropathy

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Covid shot in the arm not enough to keep pharmacies in business

Study reveals missed opportunities to deliver essential preventive care to lupus patients

Erythropoietin treatment may increase the risk of hip fractures in individuals with kidney failure

New insights on how hospitalized patients develop liver injury from taking different drugs

Generic drugs for hypertension offer a great alternative to brand-name counterparts

Study analyzes two different classes of drugs in a large group of preschoolers with ADHD

Emergency physicians use heparin alternative to treat vaccine-induced blood clot

Moderna COVID-19 vaccine makes it on WHO Emergency Use Listing

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News